Posted by Michael Wonder on 07 Apr 2022
Hundreds of people with some forms of urothelial cancer to receive new treatment
7 April 2022 - Over 800 people with locally advanced or metastatic urothelial cancer are set to benefit from a new treatment – avelumab – following its recommendation for routine NHS funding in final draft guidance published today by NICE.
The recommendation comes after a successful appeal by stakeholders against the previous recommendation made by NICE and further evidence from the company, including an increased commercial discount.
